Altered mucin expression in the gastrointestinal tract: A review

Journal of Cellular and Molecular Medicine

Volumn 5, Issue 3, 2001, Pages 327-351

  Jass, J R ^a   Walsh, M D ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Differentiation; Gastrointestinal tract; Helicobacter pylori; Histochemistry; Metaplasia neoplasia; Mucin; Polyps; Sialic acid

Indexed keywords

MUCIN; N ACETYLNEURAMINIC ACID;

CELL DIFFERENTIATION; GASTROINTESTINAL TUMOR; HUMAN; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; REVIEW; STOMACH MUCOSA;

CELL DIFFERENTIATION; GASTRIC MUCOSA; GASTROINTESTINAL NEOPLASMS; HUMANS; INTESTINAL MUCOSA; MUCINS; N-ACETYLNEURAMINIC ACID;

EID: 0035527332     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2001.tb00169.x     Document Type: Article

References (140)

1. Podolsky O.K., Oligosaccharide structures of human colonie mucin., J. Biol. Cliem., 260:826271,1985
2. Podolsky D.K., Oligosaccharide structures of isolated human colonie mucin species., J. Biol. C/iem.,260:15510-15,1985
3. Slomiany B.L., Murty V.L.N., Slomiany A., Isolation and characterization of oligosaccharides from rat colonie mucus glycoprotein, J. Biol. Chem., 255:9719-23,1980
4. Jass J.R., Roberton A.M., Colorectal mucin histochemistry in health and disease: A critical review., Pathol. Int., 44:487-504,1994
5. Feizi T., Gooi H.C., Childs R.A., et al, Tumourassociated and differentiation antigens on the carbohydrate moieties of mucin-type glycoproteins, Biochem. Soc. Trans., 12:591-96,1984
6. Picard J.K., Feizi T., Peanut lectin and anti-li antibodies reveal structural differences among human gastrointestinal glycoproteins, Mol. Immimol, 20:1215-20,1983
7. Campbell B.J., Finnic I.A., Hounsell E.F., Rhodes J.M., Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonie adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin., J. Clin. Invest., 95:571-76,1995
8. 0rntoft T.F., Langkilde N.C., Wiener H., Ottosen P.D., Cellular localization of PNA binding in colorectal adenomas: Comparison with differentiation, nuclear: cell height ratio and effect of desialylation,APA//S, 99:275-81,1991
9. Boland C.R., Montgomery C.K., Kim Y.S., Alterations in human colonie mucin occurring with cellular differentiation and malignant transformation, Proc. Natl. Acad. Sei. USA, 79:2051-55,1982
10. Boland C.R., Montgomery C.K., Kim Y.S., A cancer-associated mucin alteration in benign colonie polyps, Gastroenterology, 82:664-72,1982
11. 0rntoft T.F., Mors N.P.O., Eriksen G, Jacobsen N.O., Poulsen H.S., Comparative immunoperoxidase demonstration of T-antigens in human colorectal carcinoma and morphologically abnormal mucosa, Cancer Res., 45:447-52,1985
12. 0rntoft T.F., Harving N., Langkilde N.C., Olinked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas, Int. J. Cancer, 45:66672,1990
13. Hanski C., Hanisch F.G, Riecken E.O., Alteration of mucin-bound carbohydrate moieties in malignant transformation of colonie mucosa, Cancer J., 5:332-42,1992
14. Dabelsteen E., Graem N., Clausen H., Hakomori S.-L, Structural variations of blood group A antigens in human normal colon and carcinomas., Ca/ice/-/to.,48:181-7,1988
15. Henry S., Oriol F., Samuelson B., Lewis histoblood group system and associated secretory phenotypes., Vox. Sang., 69:166-82,1995
16. Yuan M., Itzkowitz S.H., Palekar A., et al, Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignant colonie tissue, Cancer Res., 45:4499511,1985
17. Holmes E.H., Ostrander G.K., Hakamori S., Biosynthesis of the sialyl-SLex determinant carried by type two chain glycosphingolipids in human lung carcinoma PC9 cells, J. Biol. Client., 261:3737-43,1986
18. Ajioka Y, Xing P.-X., Hinoda Y., Jass J.R., Correlative histochemical study providing evidence for the dual nature of human colorectal cancer mucin, Histochem. J., 29:143-52,1997
19. Lopez-Ferrer A., de Boles C., Barranco C, et al, Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium, Gut, 47:349-56,2000
20. Culling C.F.A., Reid P.E., Dünn W.L., A new histochemical method for the identification and visualisation of both side chain acylated and nonacylated sialic acids., J. Histochem. Cytochem., 24:1225-30,1976
21. Hanski C., Bornhoeft G, Topf N, et al, Detection of a mucin marker for the adenoma-carcinoma sequence in human colonie mucosa by monoclonal antibody AM-3,J. din. Patlwl., 43:379-84,1990
22. Jass J.R., Allison L.J., Edgar S.G, Distribution of sialosyl Tn and Tn antigens within normal and malignant colorectal epithelium., J. Pathoi, 176:143-49,1995
23. Pilbrow S.J., Hertzog P.J., Linnane A.W., The adenoma-carcinoma sequence in the colorectum early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlation with malignant potential, Br. J. Cancer, 66:74857,1992
24. Richman P.I., Bodmer W.F., Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterization, Int. J. Cancer., 39:317-28,1987
25. Hughes N.R., Walls R.S., Newland R.C., Payne J.E., Gland to gland heterogeneity in histologically normal mucosa of colon cancer patients demonstrated by monoclonal antibodies to tissuespecific antigens, Cancer Res., 46:5993-99,1986
26. Hughes N.R., Walls R.S., Newland R.C., Payne J.E., Antigen expression in normal and neoplastic colonie mucosa: three tissue-specific antigens using monoclonal antibodies to isolated colonie glands, Cancer Res., 46:2164-71,1986
27. Milton J.D., Eccleston D., Parker N, et al, Distribution of O-acetylated sialomucin in the normal and diseased gastrointestinal tract shown by a new monoclonal antibody, J: Clin. Pathoi., 46:323-29,1993
28. Sugihara K., Jass J.R., Colorectal goblet cell sialomucin heterogeneity: its relation to malignant disease, 7. Clin. Pathoi., 39:1088-95,1986
29. Campbell F., Appleton M.A., Fuller C.E., et al, Racial variation in the O-acetylation phenotype of human colonie mucosa, J. Pathoi., 174:16974,1994
30. Ogata S., Ho I., Chen A, et al, Tumor-associated sialylated antigens are constitutively expressed in normal human colonie mucosa., Cancer Res., 55:1869-74,1995
31. Jass J.R., Allison L.M., Edgar S., Monoclonal antibody TKH2 to the cancer-associated epitope sialosyl Tn shows cross-reactivity with variants of normal colorectal goblet cell mucin., Pathology, 26:418-22,1994
32. Filipe M.I., Mucins in the human gastrointestinal epithelium: a review, Invest. Cell Pathoi., 2:195216,1979
33. Hutchins J.T., Reading C.L., Giavazzi R., Hoaglund J., Jessup J.M., Distribution of mono-, di-, and tri-O-acetylated sialic acids in normal and neoplastic colon, Cancer Res., 48:483-89,1988
34. Hertzog P.J., Pilbrow S.J., Pedersen J, et al, Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies, Br. J. Cancer, 64:799-808,1991
35. Isaacson P., Attwood P.R.A., Failure to demonstrate specificity of the morphological and histochemical changes in mucosa adjacent to colonie carcinoma (transitional mucosa). J. Clin. Par/ioJ., 32:214-8,1979
36. Buisine M.P., Janin A., Maunoury V, et al, Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma, Gastroenterology, 110:84-91,1996
37. Longman R.J., Douthwaite J., Sylvester P., et al, Lack of mucin MUC5AC field change expression associated with tubulovillous and villous colorectal adenomas, J. Clin. Pathol., 53:100-04,2000
38. Itzkowitz S.H., Yuan M., Fukushi Y., et al, Lewisx- and sialylated lewisx-related antigen expression in human malignant and nonmalignant colonie tissues, Cancer Res., 46:2627-32,1986
39. Yuan M., Itzkowitz S.H., Ferrell L.D, et al, Expression of lewisx and sialylated lewisx antigens in human colorectal polyps, J. Natl. Cancer Inst., 78:479-88,1987
40. Itzkowitz S.H., Bloom E.J., Lau T.-S., Kim Y.S., Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps, Gut, 33:51823,1992
41. Ito H., Hiraiwa N., Sawada-Kasugai M., et al, Altered mRNA expression of specific molecular species of fucosyl- and sialyl- transferases in human colorectal cancer tissues, Int. J. Cancer, 71:55664,1997
42. Matsuura N., Narita T., Hiraiwa N, et al, Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer, Int. J. Oncol., 12:1157-64,1998
43. Lauren P., The two histological main types of gastric carcinoma: diffuse and so-called intestinaltype carcinoma. An attempt at a histoclinical classification, Acta. Pathol. Microbiol. Scand., 64:31-49,1965
44. Jass J.R., Smith M., Sialic acid and epithelial differentiation in colorectal polyps and cancer - a morphological, mucin and lectin histochemical study, Pathology, 24:233-42,1992
45. Tytgat K.M., van der Wal J.W., Einerhand A.W., Buller H.A., Dekker J., Quantitative analysis of MUC2 synthesis in ulcerative colitis, Biochem. Biophys. Res. Commun., 224:397-405,1996
46. Chang S.-K., Dohrman A.F., Basbaum C.B, et al, Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer., Gastroenterology, 107:28-36,1994
47. Hanski C., Born M., Foss H.D., et al, Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core, J. Pathol., 188:304-11,1999
48. Podolsky D.K., Isselbacher K.J., Composition of human colonie mucin. Selective alterations in inflammatory bowel disease., J. Clin. Invest., 72:142-53,1983
49. Raouf A., Parker N., Iddon D., et al, Ion exchange chromatography of purified colonie mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect, Gut, 32:1139-45,1991
50. Jass J.R., Sugihara K., Love S.B., Basis of sialic acid heterogeneity in ulcerative colitis, J. Clin. Pathol, 41:388-92,1988
51. Williams S.J., McGuckin M.A., Gotley D.C., et al, Two novel mucin genes down-regulated in colorectal cancer identified by differential display, Cancer Res., 59:4083-89,1999
52. Kyo K., Parkes M., Takei Y., et al, Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3, Hum. Mol. Gem, 8:307-11,1999
53. Itzkowitz S.H., Young E., Dubois D., et al, Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective casecontrol study, Gastroenterology, 110:694-704,1996
54. Kushima R., Hattori T., Okabe H., Borchard F., Stolte M., A histogenetic continuum of ulcerative colitis related lesions as revealed by immunohistochemistry for MUC2, MUC5AC and MUC6 mucins, Pathol. Int., 50 (SuppI):A80,2000
55. Shepherd N.A., Healey C.J., Warren B.E, et al, Distribution of mucosal pathology and an assessment of colonie phenotypic change in the pelvic ileal reservoir, Gut, 34:101-05,1993
56. Corfield A.P., Warren B.F., Bartolo D.C., Wagner S.A., Clamp J.R., Mucin changes in ileoanal pouches monitored by metabolic labelling and histochemistry, Br. J. Snrg., 79:1209-12,1992
57. Sylvester P.A., Walsh M.D., Myerscough N., et al., Alteration in mucin gene expression occurs as the mucosa of the ileoanal reservoir adapts, Gut, 42 (suppl):A91,1998
58. Wright N.A., Pike C., Elia G., Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulcération in human gastrointestinal stem cells, Nature, 343:82-85,1990
59. Wright N.A., Poulsom R., Stamp GW., et al, Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues, J. Pathol., 162:27984,1990
60. Ahnen D.J., Poulsom R., Stamp G.W., et al, The ulcer-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland, J. PathoL, 173:317-26,1994
61. Wright N.A., Poulsom R., Stamp G, et al, Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease, Gastroenterology, 104:12-20,1993
62. Dignass A., Lynch-Devaney K., Kindon H., Thim L., Podolsky O.K., Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway, J. Clin. Invest., 94:376-83,1994
63. Seib T., Blin N., Hilgert K, et al, The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3, Genomics, 40:200-02,1997
64. Hanby A.M., Poulsom R., Singh S., et al, Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach, Gastroenterology, 105:1110-16,1993
65. Podolsky O.K., Lynch-Devaney K., Stow J.L, et al, Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion, J. Biol. Chem., 268:6694702,1993
66. Tomasetto C., Masson R., Linares J.L., et al, pS2/TFFl interacts directly with the VWFC cysteine-rich domains of mucins, Gastroenterology, 118:70-80,2000
67. Longman R.J., Douthwaite J., Sylvester P.A., et al, Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa, Gut, 47:792-800,2000
68. van Klinken B.J., Dekker J., van Gool S.A, et al, MUC5B is the prominent mucin in human gallbladder and is also expressed in a subset of colonie goblet cells, Am. J. Pliysiol., 274:G871078,1998
69. Roberts I.S., Stoddart R.W., Ulcer-associated cell lineage ('pyloric metaplasia') in Crohn's disease: a lectin histochemical study, J. Patliol, 171:1319,1993
70. Spychal R.T., Goggin P.M., Marrero J.M, et al, Surface hydrophobicity of gastric mucosa in peptic ulcer disease: relationship to gastritis and Campylobacter pylori infection, Gastroenterology, 98:1250-54,1990
71. Sidebotham R.L., Batten J.J., Karim Q.N., Spencer J., Baron J.H., Breakdown of gastric mucus in presence of Helicobacter pylori, J. din. PathoL, 44:52-57,1991
72. Newton J.L., Jordan N., Oliver L., et al, Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised, Gut, 43:47075,1998
73. Markesich D.C., Anand B.S., Lew GM., Graham D.H., Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel, Gut, 36:327-29,1995
74. Byrd J.C., Van P., Sternberg L, et al, Aberrant expression of gland-type mucin in the surface epithelium of H. pylori-infected patients, Gastroenterology, 113:455-64,1997
75. Byrd J.C., Yunker C.K., Xu Q.S., Sternberg L.R., Bresalier R.S., Inhibition of gastric mucin synthesis by Helicobacter pylori, Gastroenterology, 118:1-9,2000
76. Rieder G, Moran A.P., Walz A., Stolte M., Enders G, Role of adherence in interleukin-8 induction in Helicobacter pylori-associaled gastritis, Infect. Immun., 65:3622-30,1997
77. Dixon M.F., Recent advances in gastritis, Curr. Diag. PathoL, 1:80-89,1994
78. Sobala GM., O'Connor HJ., Dewar E.P., et al, Bile reflux and intestinal metaplasia of gastric mucosa, J. Clin. PathoL, 46:235-40,1993
79. Reis C.A., David L., Correa P., et al, Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression, Cancer Res., 59:1003-07,1999
80. Jass J.R., Role of intestinal metaplasia in the histogenesis of gastric carcinoma, J. Clin. PathoL, 33:801-10,1980
81. Filipe M.I., Potet F., Bogomoletz W.V, et al, Incomplete sulphomucin-secreting intestinal metaplasia. Preliminary data from a prospective study from three centres, Gut, 26:1319-26,1985
82. Craanen M.E., Blok P., Dekker W., Ferwerda J., Tytgat GN.J., Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa, Dig. Dis. Sei., 36:1529-36,1991
83. Sipponen P., Seppala K., Varis K., et al, Intestinal metaplasia with colonie-type sulphomucins in the gastric mucosa; its association with gastric carcinoma, Acta. Patlwl. Microbiol. Scand., 88:217-24,1980
84. Genta R.M., Giirer I.C., Graham D.Y., et al, Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa, Gastroenterology, 111:1206-11,1996
85. Thompson J.J., Zinsser K.R., Enterline H.T., Barren's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction, Hum. PathoL, 14:42-61,1983
86. Paull A., Trier J.S., Dalton M.D, et al, The histologie spectrum of Barrett's esophagus, N. Eng. J. Med., 295:476-80,1976
87. Haggitt R.C., Tryzelaar J., Ellis F.H., Colcher H., Adenocarcinoma complicating columnar epithelium-lined (Barren's) esophagus, Am. J. Clin. Pathol., 70:1-5,191
88. Reid B.J., Weinstein W.M., Barren's esophagus and adenocarcinoma, Annu. Rev. Med., 38:47792,1987
89. Chandrasoma P.T., Lokuhetty D.M., Demeester T.R., et al, Definition of histopathologic changes in gastroesophageal reflux disease, Am. J. Sitrg. Pathol., 24:344-51,2000
90. Takubo K., Sasajima K., Yamashita K., Tanaka Y., Fujita K., Double muscularis mucosae in Barren's esophagus, Hum. Pathol, 22:115861,1991
91. Voutilainen M., Farkkila M., Juhola M., Meckin J.P., Sipponen P., Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopie erosive eosophagitis and gastritis, Gut, 45:644-48,1999
92. Arul GS., Moorghen M., Myerscough N, et al, Mucin gene expression in Barren's oesophagus: an i situ hybridisation and immunohistochemical study, Gut, 47:753-61,2000
93. Labouvie C., Machado J.C., Carneiro F., et al, Differential expression of mucins and trefoil peptides in native epithelium, Barren's metaplasia and squamous cell carcinoma of the oesophagus, J. Cancer Res. Clin. Oncol, 125:71-76,1999
94. Guillem P., Billeret V., Buisine M.-P., et al, Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus, Int. J. Cancer, 88:856-61,2000
95. Jass J.R., Mucin histochemistry of the columnar epithelium of the oesophagus. A retrospective study., J. Clin. Pathol., 34:866-87,1981
96. Duchatelle V., Potet F., Bara J., Ma J., Goldfain D., Mucin immunohistochemistry of the columnar epithelium, Virchows Arch., 414:359-63,1989
97. Li H., Walsh W.H., O'Dovvd G, et al, Mechanisms of columnar metaplasia and squamous regeneration in experimental Barren's esophagus, Endoscopy, 2:121-26,1994
98. Ormsby A.H., Goldblum J.R., Rice T.W., et al, Cytokeratin subsets can reliably distinguish Barren's esophagus from intestinal metaplasia of the stomach, Hum. Pathol., 30:288-94,1999
99. Namiot Z., Sarosiek J., Rourk R.M., Hetzel O.P., McCallum R.W., Human esophageal secretion: mucosal response to luminal acid and pepsin, Gastroenterology, 106:973-81,1994
100. Hanby A.M., Jankowski J.A., Elia G, Poulsom R., Wright N.A., Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barren's metaplasia and the native oesophageal epithelium: delineation of epithelial phenotype, J. Pathol., 173:213-19,1994
101. Eads C.A., Lord R.V., Kurumboor S.K., et al, Fields of aberrant CpG island hypermethylation in Barren's esophagus and associated adenocarcinoma, Cancer Res., 60:5021-26,2000
102. Carneiro F., Seixas M., Sobrinho-Simôes M., New elements for an updated classification of the carcinomas of the stomach, Path. Res. Pract., 191:571-84,1995
103. Hattori T., Development of adenocarcinoma in the stomach, Cancer, 57:1528-34,1986
104. Egashira Y., Shimoda T., Ikegami M., Mucin histochemical analysis of minute gastric differentiated adenocarcinoma, Pathol. Int., 49:5561,1999
105. Schlemper R.J., Itabashi M., Kato Y., et al, Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists, Lancet, 349:1725-29,1997
106. Lauwers G.Y., Shimizu M., Correa P., et al, Evaluation of gastric biopsies for neoplasia. Differences between Japanese and Western pathologists, Am. J. Surg. Pathol., 23:511-18,1999
107. Kabashima A., Yao T., Sugimachi K., Tsuneyoshi M., Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas, Histopathology, 37:51322,2000
108. Wang Y.-Z., Mitomi H., Kurihara M, et al, Gastric adenomas and superficial adenocarcinomas display distinct patterns of mucin carbohydrate and core protein expression, Histopathology, 17:25059,2000
109. Endoh Y., Tamura G, Ajioka Y., Watanabe H., Motoyama T., Frequent hypermethylation of the hMLHl gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype, A'- J- Pathol., 157:717-22,2000
110. Endoh Y., Tamura G, Motoyama T., Ajioka Y., Watanabe H., Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach, Hum. Pathol., 30:826-32,1999
111. Endoh Y., Sakata K., Tamura G, et al, Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways, J. Pathol., 191:257-63,2000
112. Machado J.C., Nogueira A.M.M.F., Carneiro F., Reis C.A., Sobrinho-Simöes M., Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC and MUC6), J. Pathol., 190:437-43,2000
113. Ajioka Y., Allison L.J., Jass J.R., Significance of MUC1 and MUC2 mutin expression in colorectal cancer., J. Clin. Pathol, 49:560-64,1996
114. Baldus S.E., Zirbes T.K., Engel S., et al, Correlation of the immunohistochemical reactivity of mutin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas, Int. J. Cancer (Pred. Oncol.), 79:13338,1998
115. Reis C.A., David L., Carvalho F., et al, Immunohistochemical study of the expression of MUC6 mutin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas, J. Histochem. Cytochem., 48:37788,2000
116. Jass J.R., Young J., Leggett B.A., Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum, Histopathology, 37:295-301,2000
117. Ajioka Y., Watanabe H., Jass J.R., MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas, J. Clin. Pathol., 50:417-21,1997
118. Blank M., Klussmann E., Kruger-Krasagakes S., et al, Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types., Int. J. Cancer, 59:301-06,1994
119. Biemer-Hiittmann A.-E., Walsh M.D., McGuckin M.A., et al, Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum, J. Histochem. Cytochem., 47:103947,1999
120. Bartman A.E., Sanderson S.J., Ewing S.I., et al, Aberrant expression of MUC5AC and MUC6 gastric mutin genes in colorectal polyps, Int. J. Cancer, 80:210-18,1999
121. Yao T., Kouzuki T., Kajiwara M., et al, 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential, J. Pathol., 187:511-17,1999
122. Bara J., Chastre E., Mahiou J., et al, Gastric Ml mucin, an early oncofetal marker of colon carcinogenesis is encoded by the MUC5AC gene, Int. J. Cancer, 75:767-73,1998
123. Jass J.R., lino H., Ruszkiewicz A., et al, Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum, Gut, 46:(inpress),2000
124. Biemer-Hiittmann A.-E., Walsh M.D., McGuckin M.A., et al, Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis, Clin. Cancer Res., 6:190916,2000
125. Deng X., Bellis S., Yan Z., Friedman E., Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta 1 in cells with nonfunctional TGF-beta receptor type III, Cell Growth Differ., 10:11-18,1999
126. Goldman H., Ming S.-C., Hickock D.F., Nature and significance of hyperplastic polyps of the human colon, Arch. Pathol., 89:349-54,1970
127. Jass J.R., Constable L., Sutherland R, et al, Adenocarcinoma of colon differentiating as dome epithelium of gut-associated lymphoid tissue, Histopathology, 36:116-20,2000
128. Agawa S., Jass J.R., Sialic acid histochemistry and the adenoma-carcinoma sequence in colorectum., J. Clin. Pathol, 43:528-32,1990
129. Fang D.-C., Jass J.R., Wang D.-X., et al, Infrequent loss of heterozygosity of APC/MCC and DCC genes in gastric cancer showing DNA microsatellite instability, J. Clin. Pathol., 52:50408,1999
130. Toyota M., Ahuja N., Ohe-Toyota M, et al, CpG island methylator phenotype in colorectal cancer, Proc. Natl. Acad. Sei. USA, 96:8681-86,1999
131. Jackson-Grusby L., Beard C., Possemato R., et al, Loss of genomic methylation causes p53dependent apoptosis and epigenetic deregulation, Nature Genet., 27:31-39,2001
132. Feinberg A.P., Vogelstein B., Hypomethylation distinguishes genes of some human cancers from their normal counterparts, Nature, 301:89-92,1983
133. Hanski C., Riede E., Gratchev A, et al, MUC2 gene suppression in human colorectal carcinomas and their métastases: in vitro evidence of the modulatory role of DNA methylation, Lab. Invest., 77:685-95,1997
134. Devine P.L., McGuckin M.A., Birrell GW, et al, Monoclonal antibodies reacting with the MUC2 mucin core protein, Br. J. Cancer, 67:1182-88,1993
135. Xing P.X., Prenzoska J., Apostolopoulos V., Karkaloutsos J., McKenzie I.F.C., Monoclonal antibodies to a MUC4 peptide react with lung cancer, Int. J. Oncol, 11:289-95,1997
136. Swallow D.M., Gendler S., Griffiths B, et al, The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM, Nature, 328:82-84,1987
137. Swallow D.M., Gendler S., Griffiths B, et al, The hypervariable gene locus PUM, which codes for the tumour associated epithelial mucins, is located on chromosome 1, within the region Iq21- 24, Ann. Hum. Genet., 51:289-94,1987
138. Gum J.R., Hicks J.W., Toribara N.W, et al, The human MUC2 intestinal mucin has cysteine-rich subdomains located both upstream and downstream of its central repetitive region., J. Biol. Chem., 267:21375-83,1992
139. Porchet N., van Chong N., Dufosse J., et al, Molecular cloning and chromosomal localisation of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs., Biochem. Biophys. Res. Commun., 175:41422,1991
140. Moniaux N., Mollet S., Porchet N., et al, Complète sequence of the human mucin MUC4: a putative cell membrane- associated mucin, Biochem. J., 338:325-33,1999